Prevention of group B streptococcal infection in neonates

Current Opinion in Infectious Diseases

Volumn 11, Issue 3, 1998, Pages 325-329

  Feldman, Robert G ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; VACCINE;

ANTIBIOTIC PROPHYLAXIS; BACTERIUM CARRIER; HUMAN; NEWBORN; NEWBORN INFECTION; PREMATURE LABOR; SHORT SURVEY; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

EID: 0031812436     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199806000-00010     Document Type: Short Survey

References (27)

1. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986; 314:1665-1669.
2. Baker CJ. Group B streptococcal infection. Clin Perinatol 1997; 24:59-70. A good recent general review of group B streptococcal infections covering mainly clinical areas.
3. Yagupsky P, Menegus MA, Powell KR. The changing spectrum of group B streptococcal disease in infants: an eleven-year experience in a tertiary care hospital. Pediatr Infect Dis J 1991; 10:801-808.
4. Rench MA, Baker CJ. Neonatal sepsis caused by a new group B streptococcal serotype. J Pediatr 1993; 122:638-640.
5. Blumberg HM, Stephens DS, Modansky M, Erwin M, Elliot J, Facklam RR, et al. Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis 1996; 173:365-373.
6. Centers for Disease Control. Decreasing incidence of perinatal group B streptococcal disease United States, 1993-1995. MMWR 1997; 46:473-477. An important paper which chronicles the modest but significant decrease in the incidence of early onset GBS infection in the USA, which is almost certainly the result of the introduction of IAP.
7. Whitney CG, Plikaytis BD, Gozansky WS, Wenger ID, Schuchat A and the Neonatal Group B Streptococcal Disease Study Group. Prevention practices for perinatal group B streptococcal disease: a multi-state surveillance analysis. Obstet Gynecol 1997; 89:28-32. This paper shows how IAP policies have only been partly taken up in the USA, but it also underlines the fact that the implementation of an appropriate policy is of major importance.
8. Dronkert ML, Ketel AG, De GR. Simultaneous occurrence of group B streptococcus and echovirus 20. Eur J Pediatr 1996; 155:915.
9. Jensen NE, Aarestrup FM. Epidemiological aspects of group B streptococci of bovine and human origin. Epidemiol Infect 1996; 117:417-422.
10. Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996; 88:811-815.
11. Silver HM, Struminsky J. A comparison of the yield of positive antenatal group B streptococcus cultures with direct inoculation in selective growth medium versus primary inoculation in transport medium followed by delayed inoculation in selective growth medium. Am J Obstet Gynecol 1996; 175:155-157.
12. Bourbeau PP, Heiter BJ, Figdore M. Use of Gen-Probe AccuProbe group B streptococcus test to detect group B streptococci in broth cultures of vaginal-anorectal specimens from pregnant women: comparison with traditional culture method. J Clin Microbiol 1997; 35:144-147.
13. American Academy of Pediatrics. AAP issues guidelines for preventing group B streptococcal infections. Am Fam Physician 1993; 47:259-261.
14. Centers for Disease Control. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 1996; 45 (RR-7):1-24.
15. American Academy of Pediatrics - Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics 1997; 99:489-496.
16. Group B Strep Support Recommendations [web page] http:// www.gbss.org.uk. [Accessed 1998].
17. Gotoff SP, Boyer KM. Prevention of early-onset neonatal group B streptococcal disease. Paediatrics 1997; 99:866-869.
18. Beri R, Lourwood DL. Chemoprophylaxis for group B streptococcus transmission in neonates. Ann Pharmacother 1997; 31:110-112.
19. Poulain P, Betremieux P, Donnio PY, Proudhon JF, Karege G, Giraud JR. Selective intrapartum anti-bioprophylaxy of group B streptococci infection of neonates: a prospective study in 2454 subsequent deliveries. Eur J Obstet Gynecol Reprod Biol 1997; 72:137-140.
20. Bloom SL, Cox SM, Bawdon RE, Gilstrap LC. Ampicillin for neonatal group B streptococcal prophylaxis; how rapidly can bactericidal concentration be achieved? Am J Obstet Gynecol 1996; 175:974-976.
21. McDuffie RS Jr, Blanton SJ, Charland SL, Gibbs RS. The effect of timing of single-dose transplacental ampicillin-sulbactam therapy for prevention of neonatal group B streptococcal colonization and bacteremia in a rabbit model. Am J Obstet Gynecol 1996; 175:406-410.
22. Wedgwood JF, Carlin EB, Benjamin BL, Weintraub A, Lasker M, Green RS, Holzman IR. Penicillin at birth can help prevent early-onset group B streptococcal disease [letter]. Pediatrics 1997; 99:651-652.
23. Friedman CA, Temple DM, Miller CJ, Rawson JE. Survival and neutrophil kinetics in infants with severe group B streptococcal disease treated with gamma globulin. J Perinatol 1997; 16:439-442.
24. McDonald H, Vigneswaran R, O'Loughlin JA. Group B streptococcal colonization and preterm labour. Aust NZ J Obstet Gynaecol 1989; 29:291-293.
25. Matorras R, Garcia Perea A, Omenaca F, Usandizaga JA, Nieto A, Herruzo R. Group B streptococcus and premature rupture of membranes and preterm delivery. Gynecol Obstet Invest 1989; 27:14-18.
26. Grable IA, Garcia PM, Perry D, Socol ML. Group B streptococcus and preterm premature rupture of membranes: a randomized, double-blind clinical trial of antepartum ampicillin. Am J Obstet Gynecol 1996; 175:1036-1042.
27. Suvorov AN, Flores AE, Ferrieri P. Cloning of the glutamine synthetase gene from group B streptococci. Infect Immun 1997; 65:191-196.